JP2021518129A5 - - Google Patents

Info

Publication number
JP2021518129A5
JP2021518129A5 JP2020550598A JP2020550598A JP2021518129A5 JP 2021518129 A5 JP2021518129 A5 JP 2021518129A5 JP 2020550598 A JP2020550598 A JP 2020550598A JP 2020550598 A JP2020550598 A JP 2020550598A JP 2021518129 A5 JP2021518129 A5 JP 2021518129A5
Authority
JP
Japan
Prior art keywords
flagellin polypeptide
polypeptide
composition
flagellin
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020550598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518129A (ja
Filing date
Publication date
Priority claimed from GBGB1804384.4A external-priority patent/GB201804384D0/en
Priority claimed from GBGB1809953.1A external-priority patent/GB201809953D0/en
Priority claimed from GBGB1811900.8A external-priority patent/GB201811900D0/en
Priority claimed from GBGB1812378.6A external-priority patent/GB201812378D0/en
Priority claimed from GBGB1813444.5A external-priority patent/GB201813444D0/en
Priority claimed from GBGB1813423.9A external-priority patent/GB201813423D0/en
Priority claimed from GBGB1816834.4A external-priority patent/GB201816834D0/en
Priority claimed from GBGB1817641.2A external-priority patent/GB201817641D0/en
Priority claimed from GBGB1901218.6A external-priority patent/GB201901218D0/en
Priority claimed from GBGB1901199.8A external-priority patent/GB201901199D0/en
Priority claimed from GBGB1901993.4A external-priority patent/GB201901993D0/en
Priority claimed from GBGB1901992.6A external-priority patent/GB201901992D0/en
Application filed filed Critical
Priority claimed from PCT/EP2019/056809 external-priority patent/WO2019180000A1/en
Publication of JP2021518129A publication Critical patent/JP2021518129A/ja
Publication of JP2021518129A5 publication Critical patent/JP2021518129A5/ja
Priority to JP2023072015A priority Critical patent/JP2023100747A/ja
Pending legal-status Critical Current

Links

JP2020550598A 2018-03-19 2019-03-19 組成物 Pending JP2021518129A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023072015A JP2023100747A (ja) 2018-03-19 2023-04-26 組成物

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
GB1804384.4 2018-03-19
GBGB1804384.4A GB201804384D0 (en) 2018-03-19 2018-03-19 Compositions
EP18178350 2018-06-18
EP18178350.7 2018-06-18
GBGB1809953.1A GB201809953D0 (en) 2018-06-18 2018-06-18 Compositions
GB1809953.1 2018-06-18
GBGB1811900.8A GB201811900D0 (en) 2018-07-20 2018-07-20 Compositions comprising bacterial strains
GB1811900.8 2018-07-20
GBGB1812378.6A GB201812378D0 (en) 2018-07-30 2018-07-30 Compositions comprising bacterial strains
GB1812378.6 2018-07-30
GB1813444.5 2018-08-17
GBGB1813444.5A GB201813444D0 (en) 2018-08-17 2018-08-17 Compositions
GB1813423.9 2018-08-17
GBGB1813423.9A GB201813423D0 (en) 2018-08-17 2018-08-17 Compositions comprising bacterial strains
GB1816834.4 2018-10-16
GBGB1816834.4A GB201816834D0 (en) 2018-10-16 2018-10-16 Compositions
GB1817641.2 2018-10-29
GBGB1817641.2A GB201817641D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GBGB1901199.8A GB201901199D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
GB1901199.8 2019-01-29
GB1901218.6 2019-01-29
GBGB1901218.6A GB201901218D0 (en) 2019-01-29 2019-01-29 Compositions
GBGB1901993.4A GB201901993D0 (en) 2019-02-13 2019-02-13 Compositions
GB1901993.4 2019-02-13
GBGB1901992.6A GB201901992D0 (en) 2019-02-13 2019-02-13 Compositions comprising bacterial strains
GB1901992.6 2019-02-13
PCT/EP2019/056809 WO2019180000A1 (en) 2018-03-19 2019-03-19 Compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023072015A Division JP2023100747A (ja) 2018-03-19 2023-04-26 組成物

Publications (2)

Publication Number Publication Date
JP2021518129A JP2021518129A (ja) 2021-08-02
JP2021518129A5 true JP2021518129A5 (enExample) 2022-03-09

Family

ID=65955185

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020550823A Pending JP2021518414A (ja) 2018-03-19 2019-03-19 細菌株を含む組成物
JP2020550598A Pending JP2021518129A (ja) 2018-03-19 2019-03-19 組成物
JP2023072015A Pending JP2023100747A (ja) 2018-03-19 2023-04-26 組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020550823A Pending JP2021518414A (ja) 2018-03-19 2019-03-19 細菌株を含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023072015A Pending JP2023100747A (ja) 2018-03-19 2023-04-26 組成物

Country Status (25)

Country Link
US (3) US11419931B2 (enExample)
EP (3) EP4046644A1 (enExample)
JP (3) JP2021518414A (enExample)
KR (2) KR102578117B1 (enExample)
CN (2) CN112004543A (enExample)
AU (2) AU2019239048B2 (enExample)
BR (2) BR112020019008A2 (enExample)
CA (2) CA3094297A1 (enExample)
CY (1) CY1125104T1 (enExample)
DK (1) DK3768284T3 (enExample)
ES (1) ES2908826T3 (enExample)
HR (1) HRP20220368T1 (enExample)
HU (1) HUE058151T2 (enExample)
IL (2) IL277422A (enExample)
LT (1) LT3768284T (enExample)
MA (1) MA52128A (enExample)
MD (1) MD3768284T2 (enExample)
MX (2) MX2020009733A (enExample)
PL (1) PL3768284T3 (enExample)
RS (1) RS63090B1 (enExample)
SG (2) SG11202009254YA (enExample)
SI (1) SI3768284T1 (enExample)
SM (1) SMT202200111T1 (enExample)
TW (2) TW202003001A (enExample)
WO (2) WO2019180051A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019180051A1 (en) 2018-03-19 2019-09-26 4D Pharma Research Limited Compositions comprising bacterial strains
WO2021113500A2 (en) * 2019-12-03 2021-06-10 Board Of Regents, The University Of Texas System Combination therapies for the treatment of cancer
EP4161541A4 (en) * 2020-06-09 2024-09-11 Flagship Pioneering Innovations VI, LLC PHYSIOLOGICALLY ACCEPTABLE COMPOSITIONS CONTAINING MICROORGANISMS OR MICROBIAL PRODUCTS
KR102461645B1 (ko) * 2020-10-20 2022-11-01 전남대학교산학협력단 플라젤린 융합 단백질을 포함하는 비알코올성 지방간질환 또는 대사증후군 예방 또는 치료용 조성물
EP4384194A4 (en) * 2021-10-08 2025-07-16 Univ Iowa State Res Found Inc USE OF DOPAMINE-PRODUCING PRODUCTS TO INCREASE VACCINE EFFECTIVENESS
CN113999923B (zh) * 2021-11-25 2024-05-14 上海金翌生物科技有限公司 小柳-原田综合症标志微生物及其应用
CN115287243B (zh) * 2022-04-15 2023-06-06 集美大学 一株变形假单胞菌flgK基因沉默菌株及其构建方法
JPWO2024096122A1 (enExample) * 2022-11-04 2024-05-10
KR102878250B1 (ko) 2023-01-11 2025-10-31 서울대학교산학협력단 코리스메이트 뮤테이즈 단백질 또는 이를 암호화하는 폴리뉴클레오티드를 포함하는 암 예방 또는 치료용 조성물

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
JPH08259450A (ja) 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk インターフェロン産生増強剤
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
EP0904784A1 (en) 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20040009937A1 (en) * 2002-01-31 2004-01-15 Wei Chen Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
US20080025977A1 (en) 2003-04-14 2008-01-31 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD59
US20060228369A1 (en) 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
JP2007116991A (ja) 2005-10-28 2007-05-17 Eternal Light General Institute Inc 機能性食品
CA2667167C (en) 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
EP1958647A1 (en) 2007-02-15 2008-08-20 Helmholtz-Zentrum für Infektionsforschung GmbH Pharmaceutical composition with bacteria for tumor treatment
EP2133092B1 (en) 2007-03-19 2015-12-09 Morishita Jintan Co., Ltd. Oral vaccine
JP2011519834A (ja) * 2008-04-25 2011-07-14 インスティチュート フォー システムズ バイオロジー フラジェリンポリペプチドワクチン
EP2486134B1 (en) * 2009-10-06 2014-01-08 Panacela Labs, Inc. Use of toll-like receptor and agonist for treating cancer
EP2663367A4 (en) 2011-01-10 2014-08-06 Cleveland Biolabs Inc USE OF GREAT-SIMILAR RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER
EP2731572B1 (en) 2011-07-13 2021-04-07 Pharmaxis Ltd. Improvements relating to delivery devices
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
ES2408279B1 (es) 2011-12-15 2014-09-09 Universidad De Las Palmas De Gran Canaria Bacteria acido láctica probiótica
FR2989002B1 (fr) 2012-04-10 2015-05-15 Beepratte Lab Compositions a base de probiotiques et d'un complexe beepollen/argile, leur preparation et leurs utilisations en nutrition et therapeutique
WO2014043593A2 (en) 2012-09-13 2014-03-20 Massachusetts Institute Of Technology Programmable drug delivery profiles of tumor-targeted bacteria
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US10480002B2 (en) * 2014-02-12 2019-11-19 Transalgae Israel Ltd. Algal based edible vaccines
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (fr) * 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520502D0 (en) * 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41708A (fr) * 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
KR102563191B1 (ko) 2017-07-05 2023-08-02 에벨로 바이오사이언시즈, 인크. 비피도박테리움 애니멀리스 ssp. 락티스를 이용한 암 치료 조성물 및 방법
BR112020002212A2 (pt) 2017-08-10 2020-07-28 4D Pharma Research Limited composições compreendendo cepas bacterianas
WO2019180051A1 (en) 2018-03-19 2019-09-26 4D Pharma Research Limited Compositions comprising bacterial strains

Similar Documents

Publication Publication Date Title
US7635479B2 (en) Composition and methods for enhancing immunogenecity of antigens
US6767542B2 (en) Compositions and methods for enhancing immunogenicity of antigens
HRP20220368T1 (hr) Pripravci entereococcus flagellin za uporabu u liječenju
CA3125184A1 (en) Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
US20080124354A1 (en) Methods for administering tumor vaccines
RU2016145464A (ru) Рекомбинантные вакцинные штаммы listeria и способы их получения
CN103772508A (zh) 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗
JP2011500718A5 (enExample)
JP2022130623A5 (enExample)
JP2011502165A (ja) 鞭毛細菌に対する免疫応答を強化する組成物および方法
CN111154806A (zh) 一种嵌合外源超级细胞因子的溶瘤病毒载体系统及其在药物中的应用
JP2018536002A5 (enExample)
RU2021109510A (ru) Вакцинация с использованием альфа 3 домена mica/b для лечения рака
FI3737397T3 (fi) Prameen kohdistetut syöpärokotteet ja niiden käytöt
JP2014139185A5 (enExample)
JP2021518414A5 (enExample)
CN111295200B (zh) 作为疫苗中的佐剂的包含合成的神经节苷脂gm3变体的纳米颗粒
Lu et al. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope
US20220152168A1 (en) Sequential heterologous boost oncolytic viral immunotherapy
PH12020500194A1 (en) Malaria vaccine
JP2022512686A5 (enExample)
CN104744594B (zh) 乙肝病毒多表位与志贺毒素的融合蛋白及其制备方法和应用
JP2006501166A5 (enExample)
JP7454320B2 (ja) アジュバントとしての腫瘍溶解性ウイルス
KR20250065615A (ko) 헬리코박터 파일로리 감염에 대한 백신